Gene Transfection for Stem Cell Therapy

被引：21
作者：
Baek K. [1 ]
Tu C. [1 ]
Zoldan J. [1 ]
Suggs L.J. [1 ]
机构：
[1] Department of Biomedical Engineering, The University of Texas at Austin, 107 West Dean Keeton, Stop C0800, Austin, 78712, TX
来源：
Current Stem Cell Reports | 2016年 / 2卷 / 1期
关键词：
Gene transfection; Non-viral transfection; Stem cell therapy; Stem cell transfection;
D O I：
10.1007/s40778-016-0029-5
中图分类号：
学科分类号：
摘要：
Genetic engineering of stem cells is a strategy that holds promise for realizing the potential therapeutic benefits of stem cell therapy. Through precise control of the stem cell genome, stem cells can replace or repair damaged tissues as well as serve as a depot for the sustained delivery of therapeutic molecules. Various individual genes, genome editing techniques, and transfection agents have been studied and developed for use in stem cell gene transfection. The goal for this review is to introduce specific genes and editing techniques used in stem cell therapy. Diverse gene transfection agents such as liposomes, polymers, dendrimers, peptides, inorganic nanoparticles, and physical transfection agents are also discussed with particular focus on stem cell considerations. © 2016, Springer International Publishing AG.
引用
收藏
页码：52 / 61
页数：9
相关论文
共 100 条
[1]  
Bhasin A., Srivastava M.V.P., Mohanty S., Et al., Stem cell therapy: a clinical trial of stroke, Clin Neurol Neurosurg, 115, 7, pp. 1003-1008, (2013)
[2]  
Chhabra P., Brayman K.L., Stem cell therapy to cure type 1 diabetes: from hype to hope, Stem Cells Transl Med, 2, 5, pp. 328-336, (2013)
[3]  
Garbern J.C., Lee R.T., Cardiac stem cell therapy and the promise of heart regeneration, Cell Stem Cell, 12, 6, pp. 689-698, (2013)
[4]  
Diekman B.O., Guilak F., Stem cell-based therapies for osteoarthritis: challenges and opportunities, Curr Opin Rheumatol, 25, 1, (2013)
[5]  
Robinton D.A., Daley G.Q., The promise of induced pluripotent stem cells in research and therapy, Nature, 481, 7381, pp. 295-305, (2012)
[6]  
Mundra V., Gerling I.C., Mahato R.I., Mesenchymal stem cell-based therapy, Mol Pharm, 10, 1, pp. 77-89, (2013)
[7]  
Bakhshandeh B., Soleimani M., Hafizi M., Et al., A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells, Cytotechnology, 64, 5, pp. 523-540, (2012)
[8]  
Mellott A.J., Forrest M.L., Detamore M.S., Physical non-viral gene delivery methods for tissue engineering, Ann Biomed Eng, 41, 3, pp. 446-468, (2013)
[9]  
Ziraksaz Z., Nomani A., Soleimani M., Et al., Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification, Int J Pharm, 448, 1, pp. 231-238, (2013)
[10]  
Muroski M.E., Morgan T.J., Levenson C.W., Et al., A gold nanoparticle pentapeptide: gene fusion to induce therapeutic gene expression in mesenchymal stem cells, J Am Chem Soc, 136, 42, pp. 14763-14771, (2014)
12345678910